Over the past several weeks, we have made significant progress in planning for the combination of our generics business with Teva. Recently, we announced a number of top-level leadership appointments. At the same time, functional leaders from both companies have been working closely together to begin designing team structures for the next layers of management for the future, combined generics organization.